← Eichor
Study identifier: NCT06812832 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Simethicone as Part of ERAS in Bariatric Surgery Patients

Condition: Simethicone · Bariatric Surgery · Post-operative Pain  ·  Sponsor: Madigan Army Medical Center

PhasePhase 4
Planned participants260
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersYes

About this study

By conducting this study, we hope to assess if simethicone (also known as Gas Relief or GasX) has an effect on improving gas pain and bloating specifically in patients undergoing foregut procedures to include bariatric procedures (sleeve gastrectomy, Roux-en-Y gastric bypass), hiatal hernia, and gastric surgery. The purpose of this research is to gather information on the safety and effectiveness of simethicone. Simethicone (more commonly known as Gas Relief or Gas-X) relieves pressure, bloating, and fullness commonly referred to as gas. It is FDA approved. The use of this medication in this research study is consistent with labeling indications.

This description comes directly from the study's public registry record.

Talk to the study team

Brooklyn Williams, DO  ·  (253) 968-3105  ·  brooklyn.c.williams3.mil@health.mil

Christopher Porta, MD  ·  (253) 968-3105  ·  christopher.r.porta.civ@health.mil

Always discuss trial participation with your own doctor first.

Locations (1)

Madigan Army Medical CenterTacoma, Washington, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06812832